Skip to content

ABUS

Arbutus Biopharma Corp

NASDAQ · Healthcare · Biotechnology · US

$4.23
+0.24%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
5.64x
P/E 2027E
—
P/E 2028E
—
P/S forward
209.50x

Trailing multiples

Trailing twelve months

P/E TTM
5.35x
PEG TTM
—
Price / book
3.24x
Price / sales
4.61x
Price / cash flow
-34.03x

Enterprise value

Enterprise value
$749.0M
EV / sales
4.12x
EV / EBITDA
4.89x
EV / EBIT
5.09x
Market cap
$838.0M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026